Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2018

Open Access 01-12-2018 | Research article

Terminalia bellirica fruit extracts: in-vitro antibacterial activity against selected multidrug-resistant bacteria, radical scavenging activity and cytotoxicity study on BHK-21 cells

Authors: M. Priyanga Jayamal Dharmaratne, Amirthasingam Manoraj, Vasanthi Thevanesam, Asela Ekanayake, Nimal Savitri Kumar, Veranja Liyanapathirana, Eranga Abeyratne, B. M. Ratnayake Bandara

Published in: BMC Complementary Medicine and Therapies | Issue 1/2018

Login to get access

Abstract

Background

Identification of novel sources for developing new antibiotics is imperative with the emergence of antibiotic resistant bacteria. The fruits of Terminalia bellirica (Gaertn) Roxb., widely used in traditional medicine, were evaluated for antibacterial activity against multidrug-resistant (MDR) bacteria, antioxidant activity and cytotoxicity.

Methods

Twelve solvent extracts of T. bellirica fruits were prepared by direct aqueous extraction and sequential extraction with dichloromethane, methanol and water using Soxhlet, bottle-shaker and ultrasound sonicator methods. Antibacterial activity of the extracts was tested against 16 strains MDR bacteria—methicillin-resistant Staphylococcus aureus (MRSA), extended spectrum β-lactamase (ESBL) producing Escherichia coli and MDR Acinetobacter spp., Klebsiella pneumoniae and Pseudomonas aeruginosa—and 4 control organisms, using the cut-well diffusion method. The minimum inhibitory concentration (MIC) was determined using an agar dilution method. The radical scavenging activity of six antibacterial extracts was screened against 2,2′-diphenyl-2-picrylhydrazyl (DPPH) and correlation was established between EC50 (50% effective concentration) values and the total phenolic content (TPC). Cytotoxicity was determined for the most potent antibacterial extract on baby hamster kidney (BHK-21) cells by Tryphan Blue exclusion method. Statistical analysis was carried out by one-way analysis of variance at significant level p < 0.05 using “SigmaPlot 10” and “R 3.2.0” software.

Results

All aqueous and methanol extracts displayed antibacterial activity (MIC 0.25–4 mg/mL) against all strains of MRSA, MDR Acinetobacter spp. and MDR P. aeruginosa. The sequential aqueous extracts (MIC, 4 mg/mL) inhibited ESBL producing-E. coli. None of the extracts exhibited activity against MDR K. pneumoniae (MIC > 5 mg/mL). The sequential methanol extract (Soxhlet) recorded high antibacterial activity and the highest DPPH radical scavenging activity (EC50, 6.99 ± 0.15 ppm) and TPC content (188.71 ± 2.12 GAE mg/g).
The IC50 (50% inhibition concentration) values of the most potent antibacterial extract—the direct aqueous extract from reflux method—on BHK-21 cells were 2.62 ± 0.06 and 1.45 ± 0.08 mg/ml with 24 and 48 h exposure, respectively.

Conclusions

Results indicate that T. bellirica fruit is a potential source for developing broad-spectrum antibacterial drugs against MDR bacteria, which are non-toxic to mammalian cells and impart health benefits by high antioxidant activity.
Literature
2.
go back to reference World Health Organization. Antimicrobial resistance: global report on surveillance. Geneva, WHO; 2014. http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748eng.pdf. Accessed 28 Aug 2017. World Health Organization. Antimicrobial resistance: global report on surveillance. Geneva, WHO; 2014. http://​apps.​who.​int/​iris/​bitstream/​10665/​112642/​1/​9789241564748eng.​pdf.​ Accessed 28 Aug 2017.
3.
go back to reference Woodford N, Livermore DM. Infections caused by Gram-positive bacteria: a review of the global challenge. J Inf Secur. 2009;59(S1):S4–16. Woodford N, Livermore DM. Infections caused by Gram-positive bacteria: a review of the global challenge. J Inf Secur. 2009;59(S1):S4–16.
4.
go back to reference Hatcher JC, Dhillon R, Azadian B. Antibiotic resistance mechanisms in the intensive care unit. J Intensive Care Soc. 2012;13:298–302.CrossRef Hatcher JC, Dhillon R, Azadian B. Antibiotic resistance mechanisms in the intensive care unit. J Intensive Care Soc. 2012;13:298–302.CrossRef
6.
go back to reference Lim YK, Lee M-K, Kim T-H. Management of extended-spectrum beta-lactamase-positive Gram-negative bacterial urologic infections. Urogenit Tract Infect. 2015;10:84–91.CrossRef Lim YK, Lee M-K, Kim T-H. Management of extended-spectrum beta-lactamase-positive Gram-negative bacterial urologic infections. Urogenit Tract Infect. 2015;10:84–91.CrossRef
7.
go back to reference Sumathi P, Parvathi A. Antimicrobial activity of some traditional medicinal plants. J Med Plants Res. 2010;4:316–21. Sumathi P, Parvathi A. Antimicrobial activity of some traditional medicinal plants. J Med Plants Res. 2010;4:316–21.
8.
go back to reference World Health Organization. WHO Traditional Medicine Strategy 2002-2005. WHO/EDM/TRM/2002.1. Geneva: WHO; 2002. World Health Organization. WHO Traditional Medicine Strategy 2002-2005. WHO/EDM/TRM/2002.1. Geneva: WHO; 2002.
9.
go back to reference Bandara BMR. Medicinal plants to mitigate the problem of antibiotic resistance. Cey J Sci. 2017;46:1–3.CrossRef Bandara BMR. Medicinal plants to mitigate the problem of antibiotic resistance. Cey J Sci. 2017;46:1–3.CrossRef
10.
go back to reference Chauhan B, Kumawat RC, Kotecha M, Ramamurthy A, Nathani S. Triphala: a comprehensive Ayurvedic review. Int J Res Ayurveda Pharm. 2013;4:612–7.CrossRef Chauhan B, Kumawat RC, Kotecha M, Ramamurthy A, Nathani S. Triphala: a comprehensive Ayurvedic review. Int J Res Ayurveda Pharm. 2013;4:612–7.CrossRef
11.
go back to reference Sabu MC, Kuttan R. Antidiabetic and antioxidant activity of T. bellirica Roxb. Indian J Exp Biol. 2009;47:270–5.PubMed Sabu MC, Kuttan R. Antidiabetic and antioxidant activity of T. bellirica Roxb. Indian J Exp Biol. 2009;47:270–5.PubMed
12.
go back to reference Khan AU, Gilani AH. Anti-secretory and analgesic activities of Terminalia belerica. Afr J Biotechnol. 2010;9:2717–9. Khan AU, Gilani AH. Anti-secretory and analgesic activities of Terminalia belerica. Afr J Biotechnol. 2010;9:2717–9.
13.
go back to reference Shinde SL, Wadje SS. More SM, Junne SB. The antifungal activity of five Terminalia species checked by paper disc method. Int J Pharm Res Dev. 2011;3:36–40. Shinde SL, Wadje SS. More SM, Junne SB. The antifungal activity of five Terminalia species checked by paper disc method. Int J Pharm Res Dev. 2011;3:36–40.
14.
go back to reference Elizabeth KM. Antimicrobial activity of Terminalia bellirica. Indian J Clin Bioch. 2005;20:150–3.CrossRef Elizabeth KM. Antimicrobial activity of Terminalia bellirica. Indian J Clin Bioch. 2005;20:150–3.CrossRef
15.
go back to reference Choudhary GP. Anti-ulcer activity of the ethanolic extract of Terminalia belerica Roxb. Int J Pharm Chem Sci. 2012;1:1293–7. Choudhary GP. Anti-ulcer activity of the ethanolic extract of Terminalia belerica Roxb. Int J Pharm Chem Sci. 2012;1:1293–7.
16.
go back to reference Deb A, Barua S, Das B. Pharmacological activities of Baheda (Terminalia bellerica): a review. J Pharmacog Phytochem. 2016;5:194–7. Deb A, Barua S, Das B. Pharmacological activities of Baheda (Terminalia bellerica): a review. J Pharmacog Phytochem. 2016;5:194–7.
17.
go back to reference Saraswathi MN, Karthikeyan M, Kannan M, Rajasekar S. Terminalia belerica Roxb. – A phytopharmacological review. Int J Res Pharm Sci. 2012;3:96–9. Saraswathi MN, Karthikeyan M, Kannan M, Rajasekar S. Terminalia belerica Roxb. – A phytopharmacological review. Int J Res Pharm Sci. 2012;3:96–9.
18.
go back to reference Cacciapuoti F. Oxidative stress as “mother” of many human diseases at strong clinical impact. J Cardiovasc Med Cardiol. 2016;3:1–6.CrossRef Cacciapuoti F. Oxidative stress as “mother” of many human diseases at strong clinical impact. J Cardiovasc Med Cardiol. 2016;3:1–6.CrossRef
19.
go back to reference Guleria S, Tiku AK, Rana S. Antioxidant activity of acetone extract/fractions of Terminalia bellerica Roxb. fruit. Indian J Biochem Biophys. 2010;47:110–6. Guleria S, Tiku AK, Rana S. Antioxidant activity of acetone extract/fractions of Terminalia bellerica Roxb. fruit. Indian J Biochem Biophys. 2010;47:110–6.
20.
go back to reference Nampoothiri SV, Binil Raj SS, Prathapan A, Abhilash PA, Arumughan C, Sundaresan A. In vitro antioxidant activities of the methanol extract and its different solvent fractions obtained from the fruit pericarp of Terminalia bellerica. Nat Prod Res. 2011;25:277–87.CrossRefPubMed Nampoothiri SV, Binil Raj SS, Prathapan A, Abhilash PA, Arumughan C, Sundaresan A. In vitro antioxidant activities of the methanol extract and its different solvent fractions obtained from the fruit pericarp of Terminalia bellerica. Nat Prod Res. 2011;25:277–87.CrossRefPubMed
21.
go back to reference Hazra B, Sarkar R, Biswas S, Mandal N. Comparative study of the antioxidant and reactive oxygen species scavenging properties in the extracts of the fruits of Terminalia chebula, Terminalia belerica and Emblica officinalis. BMC Complement Altern Med. 2010;10:20.CrossRefPubMedPubMedCentral Hazra B, Sarkar R, Biswas S, Mandal N. Comparative study of the antioxidant and reactive oxygen species scavenging properties in the extracts of the fruits of Terminalia chebula, Terminalia belerica and Emblica officinalis. BMC Complement Altern Med. 2010;10:20.CrossRefPubMedPubMedCentral
22.
go back to reference Sireeratawong S, Jaijoy K, Panunto W, Nanna U, Lertprasertsuke N, Soonthornchareonnon N. Acute and chronic toxicity studies of the water extract from dried fruit of T. bellirica (Gaertn) Roxb. in Spargue-Dawley Rats. Afr J Tradit Complemen Altern Med. 2013;10:223–31. Sireeratawong S, Jaijoy K, Panunto W, Nanna U, Lertprasertsuke N, Soonthornchareonnon N. Acute and chronic toxicity studies of the water extract from dried fruit of T. bellirica (Gaertn) Roxb. in Spargue-Dawley Rats. Afr J Tradit Complemen Altern Med. 2013;10:223–31.
23.
go back to reference Jayesh K, Helen LR, Vysakh A, Binil E, Latha MS. In vivo toxicity evaluation of aqueous acetone extract of Terminalia bellirica (Gaertn.) Roxb. Fruit. Regulatatory Toxico Pharm. 2017;86:349–55.CrossRef Jayesh K, Helen LR, Vysakh A, Binil E, Latha MS. In vivo toxicity evaluation of aqueous acetone extract of Terminalia bellirica (Gaertn.) Roxb. Fruit. Regulatatory Toxico Pharm. 2017;86:349–55.CrossRef
24.
go back to reference Nittayajaiprom W, Sangthong P, Chancharunee S, Wipatanawin A, Wanasawas P, Chulasiri M. Mutagenicity, antimutagenicity and tyrosinase inhibition activity of hydroglycol extracts from Terminalia chebula Retzius, Terminalia bellerica Roxb and Rafflesia kerrii Meijer. Int J Phytomed. 2014;6:93–102. Nittayajaiprom W, Sangthong P, Chancharunee S, Wipatanawin A, Wanasawas P, Chulasiri M. Mutagenicity, antimutagenicity and tyrosinase inhibition activity of hydroglycol extracts from Terminalia chebula Retzius, Terminalia bellerica Roxb and Rafflesia kerrii Meijer. Int J Phytomed. 2014;6:93–102.
25.
go back to reference CLSI. Performance standards for antimicrobial susceptibility testing. 23rd Informational Supplement. CLSI document M100-S23. Wayne: Clinical and Laboratory Standards Institute; 2013. CLSI. Performance standards for antimicrobial susceptibility testing. 23rd Informational Supplement. CLSI document M100-S23. Wayne: Clinical and Laboratory Standards Institute; 2013.
26.
go back to reference Dharmaratne MPJ, Manoraj A, Thevanesam V, Bandara BMR, Kumar NS, Ekanayake EWMA. Antibacterial activity of aqueous extracts of Terminalia chebula fruit against some multidrug-resistant human pathogens. Int J Res in Pharm Biomed Sci. 2013;4:1333–7. Dharmaratne MPJ, Manoraj A, Thevanesam V, Bandara BMR, Kumar NS, Ekanayake EWMA. Antibacterial activity of aqueous extracts of Terminalia chebula fruit against some multidrug-resistant human pathogens. Int J Res in Pharm Biomed Sci. 2013;4:1333–7.
27.
go back to reference Andrews JM. Determination of minimum inhibitory concentration. J Antimicrob Chemother. 2001;48(Suppl 1):5–16.CrossRefPubMed Andrews JM. Determination of minimum inhibitory concentration. J Antimicrob Chemother. 2001;48(Suppl 1):5–16.CrossRefPubMed
28.
go back to reference Zhang WW, Duan XJ, Huang HL, Zhang Y, Wang BG. Evaluation of 28 marine algae from the Qingdao coast for anti-oxidative capacity and determination of antioxidant efficiency and total phenolic content of fractions and subfractions derived from Symphyocladia latiuscula (Rhodomelaceae). J Appl Phycol. 2007;19:97–108.CrossRef Zhang WW, Duan XJ, Huang HL, Zhang Y, Wang BG. Evaluation of 28 marine algae from the Qingdao coast for anti-oxidative capacity and determination of antioxidant efficiency and total phenolic content of fractions and subfractions derived from Symphyocladia latiuscula (Rhodomelaceae). J Appl Phycol. 2007;19:97–108.CrossRef
29.
go back to reference Antolovich M, Prenzler PD, Patsalides E, McDonald S, Robards K. Methods for testing antioxidant activity. Analyst. 2002;127:183–98.CrossRefPubMed Antolovich M, Prenzler PD, Patsalides E, McDonald S, Robards K. Methods for testing antioxidant activity. Analyst. 2002;127:183–98.CrossRefPubMed
30.
go back to reference Jirasripongpun K, Wongarethornkul T, Mulliganavin S. Risk assessment of Triclosan using animal cell lines. Kasetsart J (Nat Sci). 2008;42:353–9. Jirasripongpun K, Wongarethornkul T, Mulliganavin S. Risk assessment of Triclosan using animal cell lines. Kasetsart J (Nat Sci). 2008;42:353–9.
32.
go back to reference Beveridge TJ. Structures of gram-negative cell walls and their derived membrane vesicles. J Bacteriol. 1999;181:4725–33.PubMedPubMedCentral Beveridge TJ. Structures of gram-negative cell walls and their derived membrane vesicles. J Bacteriol. 1999;181:4725–33.PubMedPubMedCentral
33.
go back to reference Jinukti MG, Giri A. Antimicrobial activity of aqueous extract of Terminalia chebula Retz. Recent Res Sci Tech. 2013;5:46–9. Jinukti MG, Giri A. Antimicrobial activity of aqueous extract of Terminalia chebula Retz. Recent Res Sci Tech. 2013;5:46–9.
34.
go back to reference Mehrad B, Nina M, Clark NM, Zhanel GG, Lynch JP III. Antimicrobial resistance in hospital-acquired Gram-negative bacterial infections. Chest. 2015;147:1413–21.CrossRefPubMedPubMedCentral Mehrad B, Nina M, Clark NM, Zhanel GG, Lynch JP III. Antimicrobial resistance in hospital-acquired Gram-negative bacterial infections. Chest. 2015;147:1413–21.CrossRefPubMedPubMedCentral
35.
go back to reference Jamkhande PG, Wattamwar AS, Pekamwar SS, Chandak PG. Antioxidant, antimicrobial activity and in silico PASS prediction of Annona reticulata Linn. root extract. Beni_Suef Univ J Basic App Sci. 2014;3:140–8.CrossRef Jamkhande PG, Wattamwar AS, Pekamwar SS, Chandak PG. Antioxidant, antimicrobial activity and in silico PASS prediction of Annona reticulata Linn. root extract. Beni_Suef Univ J Basic App Sci. 2014;3:140–8.CrossRef
36.
go back to reference Genwali GR, Acharya PP, Rajbhandari M. Isolation of gallic acid and estimation of total phenolic content in some medicinal plants and their antioxidant activity. Nepal J Sci Tech. 2013;14:95–102.CrossRef Genwali GR, Acharya PP, Rajbhandari M. Isolation of gallic acid and estimation of total phenolic content in some medicinal plants and their antioxidant activity. Nepal J Sci Tech. 2013;14:95–102.CrossRef
37.
go back to reference Aqil F, Ahmad I, Mehmood Z. Antioxidant and free radical scavenging properties of twelve traditionally used Indian medicinal plants. Turk J Biol. 2006;30:177–83. Aqil F, Ahmad I, Mehmood Z. Antioxidant and free radical scavenging properties of twelve traditionally used Indian medicinal plants. Turk J Biol. 2006;30:177–83.
38.
go back to reference Singh R, Singh B, Kumarb N, Arora S. Antioxidant activity of Triphala, a combination of Terminalia chebula, Terminalia bellerica and Emblica officinalis. J Food Biochem. 2010;34:222–32.CrossRef Singh R, Singh B, Kumarb N, Arora S. Antioxidant activity of Triphala, a combination of Terminalia chebula, Terminalia bellerica and Emblica officinalis. J Food Biochem. 2010;34:222–32.CrossRef
39.
go back to reference Zirihi GN, Mambu L, Guédé-Guina F, Bodo B, Grellier P. In vitro antiplasmodial activity and cytotoxicity of 33 West African plants used for treatment of malaria. J Ethnopharmacol. 2005;98:281–5.CrossRef Zirihi GN, Mambu L, Guédé-Guina F, Bodo B, Grellier P. In vitro antiplasmodial activity and cytotoxicity of 33 West African plants used for treatment of malaria. J Ethnopharmacol. 2005;98:281–5.CrossRef
Metadata
Title
Terminalia bellirica fruit extracts: in-vitro antibacterial activity against selected multidrug-resistant bacteria, radical scavenging activity and cytotoxicity study on BHK-21 cells
Authors
M. Priyanga Jayamal Dharmaratne
Amirthasingam Manoraj
Vasanthi Thevanesam
Asela Ekanayake
Nimal Savitri Kumar
Veranja Liyanapathirana
Eranga Abeyratne
B. M. Ratnayake Bandara
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2018
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-018-2382-7

Other articles of this Issue 1/2018

BMC Complementary Medicine and Therapies 1/2018 Go to the issue